Совершенствование экстренной профилактики и лечения опасных инфекций с помощью иммуномодуляторов

60. Cheng, A. C. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis / A. C. Cheng, D. P. Stephens, N. M. Anstey, B. J. Currie // Clin. Infect. Dis. - 2004. - Vol. 38, № 1. - P. 32-37.

61. Cheng, A. C. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand / A. C. Cheng, D. Limmathurotsakul, W. Chierakul, N. Getchalarat,

V. Wuthiekanun, D. P. Stephens, N. P. Day, N. J. White, W. Chaowagul, B. J. Currie, S. J. Peacock // Clin. Infect. Dis. - 2007. - Vol. 45, № 3. - P. 308-314.

62. Cheng, A. C. Granulocyte colony-stimulating factor and in vitro whole blood model of melioiodosis / A. C. Cheng, P. Dasari, B. Y. Currie // Eur. J. Clin. Microbiol. Infect. Dis. - 2004. - Vol. 23, № 3. - P. 205-207.

63. Chitu, V. Colony-stimulating factor-1 in immunity and inflammation / V. Chitu, Е. Stanley // Curr. Opin. Immunol. - 2006. - № 18. - P. 39-48.

64. Garcia, A. E. Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes / А. Е. Garcia, G. Osapay, P. A. Tran, J. Yuan // Selsted ME. Infect Immun. - 2008. - Vol. 76, № 12. - P. 5883-5891.

65. Haque, A. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection / A. Haque, A. Easton, D. Smith, A. O'Garra, N. Van Rooijen, G. Lertmemongkolchai, R. W. Titball, G. J. Bancroft // J. Infect. Dis. - 2006. - Vol. 193, № 3. - P. 370-379.

66. Lauw, F. N. The CXC chemokines gamma interferon (IFN-gamma) - inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis / F. N. Lauw, A. J. Simpson, J. M. Prins, S. J. van Deventer, W. Chaowagul, N. J. White, T. van der Poll // Infect. Immun. - 2000. - Vol. 68. - P. 2034-2042.

67. Nicamp, F. P. Principles of Immunopharmacology / F. P. Nicamp, M. J. Parnham. - Springer, 2011. - 760 p.

68. Pammit, M. A. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection / M. A. Pammit // Antimicrob Agents Chemother. - 2004. - Vol. 48, № 12. - P. 4513-4519.

69. Propst, K. L. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection / K. L. Propst, R. M. Troyer, L. M. Kellihan, H. P. Schweizer, S. W. Dow // Antimicrob Agents Chemother. - 2010. - Vol. 54, № 5. - P. 1785-1792.

70. Santanirand, P. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei / P. Santanirand, V. S. Harley, D. A. Dance, B. S. Drasar, G. J. Bancroft // Infect. Immun. - 1999. - Vol. 67. - P. 3593-3600.

71. Sharm, A. Vibriocidal activity of certain medicinal plants in Indian folklore medicine by tribals of Mahako- shal region of central India / A. Sharm, V. K. Patel, A. N. Chaturvedi // Indian J. Pharmacol. - 2009. - Vol. 41, № 3. - P. 129-133.

72. Skyberg, J. A. Nasal acai polysaccharides potential innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei infections / J. A. Skyberg // PLoS Pathog. - 2012. - Vol. 8, № 3. - P. e 1002587.

73. Stephens, D. P. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock / D. P. Stephens, J.H. Thomas, A. Higgins, M. Bailey, N. M. Anstey, B. J. Currie, A. C. Cheng // Crit. Care Med. - 2008. - Vol. 36, № 2. - P. 448-454.

74. Utaisincharoen, P. Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei nfected mouse macrophages / P. Utaisincharoen,

N. Anuntagool, S. Arjcharoen, K. Limposuvan, P. Chisuria, S. Sirisinha // Exp. Immunol. - 2004. - Vol. 136, № 2. - P. 277-283.

75. Wiersinga, W. J. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis / W. J. Wiersinga, K. U. Wieland, H. J. V. van der Windt, A. de Bourg, S. Florkin, A. Dondorp, N. P. Day, Sh. J. Peacock, T. van der Poll // Infect. Immun. - 2007. - Vol. 75, № 8. - P. 3739-3746.

76. Wiersinga, W. J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei /

W. J. Wiersinga, T. van der Poll, N. J. White, N. P. Day, S. G. Koh, S. J. Peacock // Europ. J. Clin. Microbiol and Inf. Dis. - 2012. - Vol. 31, № 4. - P. 379-388.

77. Xiao, B. G. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection / B. G. Xiao,

C. Z. Lu, Н. Lin // J. Cel. Mol. Med. - 2007. - Vol. 11, № 6. - P. 1272-1290.

78. Yamasaki, S. Inhibition of virulence potential of Vibrio cholerae by natural compounds / S. Yamasaki, M. Asakura, S. B. Neogi, A. Hinenoya, E. Iwaoka, S. Aoki // Indian J. Med. Res. - 2011. - Vol. 133, № 2. - P. 232-239.

References

1. Arefeva E. V., Babusenko M. S., Baryshev E. M., Bobreshov D. A., Boreyko V. Ya., Vereskun A. V., Glebov V. Yu., Efimova A. A., Zheleznov A. A., Kozacha V. M., Korovin A. I., Kotosonov A. S., Lisitsa B. N., Molchanov S. A., Morozova O. A., Oltyan I. Yu., Papkov S. V., Posokhov N. N., Sosunov I. V., Khalimova A. S., Chesnokov V. M. Problemy zashchity naseleniya i territoriy v chrezvychaynykh situatsiyakh v usloviyakh sovremen- nykh vyzovov i ugroz. Spravochnoe posobie [Problems of protection of the population and territories in emergency situations in the context of modern challenges and threats. Reference guide]. Ed. I. V. Sosunov. Moscow, Vserossiyskiy nauchno-issledovatel'skiy institut po problemam grazhdanskoy oborony i chrezvychaynykh situatsiy MChS Rossii [All-Russian Research Institute for Civil Defense and Emergencies EMERCOM of Russia], 2017, 452 p.

2. Afanas'ev S. S., Aleshkin V. A., Vorob'ev A. N., Fetisova L. V., Popov V. F., Nesvizhskiy Yu. V., Meskina E. R., Afanas'ev M. S., Man'ko T. N., Rubal'skiy O. V. Interferonoterapiya infektsionnykh zabolevaniy - sostoyanie problemy i perspektivy [Interferon therapy of infectious diseases - state of the problem and prospects]. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology], 2005, no. 6, pp. 94-99.

3. Barinov O. V., Konusova V. G., Salamatov A. V., Kotiv B. N., Simbirtsev A. S. Ispol'zovanie lyuminolzav- isimoy khemilyuminestsentsii dlya otsenki funktsional'noy aktivnosti fagotsitarnoy sistemy pri lechenii rekombinant- nym interleykinom-1 beta gnoyno-destruktivnykh zabolevaniy legkikh i plevry [The use of luminol-dependent chemiluminescence to assess the functional activity of the phagocytic system in the treatment of recombinant interleukin-1 beta purulent-destructive diseases of the lungs and pleura]. Rossiyskiy immunologicheskiy zhurnal [Russian immunological journal], 2010, vol. 4 (13), no. 1, pp. 68-76.

4. Baymuradov F. U. Novyy immunomoduliruyushchiy preparat glutoksim kak sredstvo profilaktiki i terapii ostrykh respiratornykh virusnykh infektsiy v obshchey vrachebnoy praktike. Avtoreferat dissertatsii kandidata meditsin- skikh nauk [New immunomodulating drug Glutoxim as a means of prevention and treatment of acute respiratory viral infections in general practice. Abstract of thesis of Candidate of Medical Sciences]. Saint Petersburg, 2003, 21 p.

5. Bezpal'ko Yu. V., Ziganshin O. R., Ryshkov V. L., Kolobov A. A., Simbirtsev A. S. Bestim i betaleykin v kompleksnoy terapii khronicheskoy gonokokkovoy infektsii mochepolovykh organov u zhenshchin [Bestim and betaleykin in the complex therapy of chronic gonococcal infection of the urinary organs in women]. Tsitokiny i vospalenie [Cytokines and inflammation], 2008, vol. 7, no. 4, pp 58-62.

6. Beniova S. N., Markelova E. V. Immunokorrektsiya retsidiviruyushchego techeniya psevdotuberkuleza u de- tey [Immunocorrection of recurrent pseudotuberculosis in children]. Tsitokiny i vospalenie [Cytokines and inflammation], 2003, vol. 2, no. 3, pp. 13-17.

7. BondarevaT. A., PoyarkovA. Yu., Vakhnov E. Yu. Ispol'zovanie polioksidoniya v kompleksnom lechenii generalizovannykh form eksperimental'noy chumy [The use of polyoxidonium in the complex treatment of generalized forms of experimental plague]. Problemy osobo opasnykh infektsiy [Problems of especially dangerous infections], 2009, no. 99, pp. 67-69.

8. Bondareva T. A., Kalininskiy V. B., Borisevich I. V., Baramzina G. V., Fomenkov O. O. Sravnitel'naya ot- senka effektivnosti sovremennykh ftorkhinolonov pri lechenii eksperimental'noy tulyaremii [Comparative evaluation of the effectiveness of modern fluoroquinolones in the treatment of experimental tularemia]. Problemy osobo opasnykh infektsiy [Problems of especially dangerous infections], 2008, no. 3 (97), pp. 43-45.

9. Bondareva T. A., Kalininskiy V. B., Borisevich I. V., Bondarev V. P., Fomenkov O. O. Effektivnost' sovre- mennykh ftorkhinolonov pri ekstrennoy profilaktike i lechenii eksperimental'nogo sapa [The effectiveness of modern fluoroquinolones in emergency prevention and treatment of experimental glanders]. Voenno-meditsinskiy zhurnal [Military Medical Journal], 2008, vol. 329, no. 11, pp. 78-79.

10. Bubnova N. A., Egorova V. N. Obobshchennyy opyt primeneniya ronkoleykina (rekombinantnogo inter- leykina-2) v lechenii khirurgicheskikh zabolevaniy: posobie dlya vrachey [Generalized experience of using Ronco- leukin (recombinant interleukin-2) in the treatment of surgical diseases: a manual for doctors]. Saint Petersburg, Alter ego, 2010, 80 p.

11. Burgasova O. A., Yushuk N. D., Voskresenskaya E. A., Tseneva G. A. Protektivnoe vliyanie preparata «Bestim» na techenie eksperimental'noy psevdotuberkuleznoy infektsii [The protective effect of the drug “Bestim” on the course of experimental pseudotuberculosis infection]. Zdorov'e natsii i sreda obitaniya [Nation Health and Habitat], 2011, no. 6. pp. 27-29.

12. Varyushina E. A., Moskalenko V. V., Lebedeva T. P., Bubnov A. N., Simbirtsev A. S. Ispol'zovanie inter- leykina-1 beta dlya mestnogo lecheniya gnoyno-nekroticheskikh porazheniy nizhnikh konechnostey [The use of interleukin-1 beta for the local treatment of purulent-necrotic lesions of the lower extremities]. Meditsinskaya immunologiya [Medical immunology], 2008, vol. 10, no. 4-5, pp. 439-448.

13. Dolmatova L. S., Zaika O. A., Nedashkovskaya E. N., Timchenko N. F. Issledovanie mekhanizmov apop- tozmoduliruyushchego vliyaniya termostabil'nogo toksina Yersinia pseudotuberculosis i korrigiruyushchego deystviya ekstrakta iz dal'nevostochnykh vidov goloturiy na neytrofily krys in vitro [Investigation of the mechanisms of the apoptosis modulating effect of the thermostable toxin Yersinia pseudotuberculosis and the corrective effect of the extract from Far Eastern species of holothuria on rat neutrophils in vitro]. Tikhookeanskiy meditsinskiy zhurnal [Pacific Medical Journal], 2010, no. 3, pp. 76-80.

14. El'kin A. V. Issledovanie effektivnosti i perenosimosti ronkoleykina pri lechenii progressiruyushchego tu- berkuleza legkikh [Study of the efficacy and tolerability of Roncoleukin in the treatment of advanced pulmonary tuberculosis]. Posobie dlya vrachey [Manual for doctors]. Saint Petersburg, Alter Ego, 2009, 35 p.

15. Eryukhin I. A., Shlyapnikov S. A. Problema peritonita i abdominal'nyy sepsis [The problem of peritonitis and abdominal sepsis]. Consilium medicum, 2005, vol. 7, no. 6, pp. 468-472.

16. Zheleznikova G. F Rol' tsitokinov v patogeneze i diagnostike infektsionnykh zabolevaniy [The role of cytokines in the pathogenesis and diagnosis of infectious diseases]. Infektsionnye bolezni [Infectious diseases], 2008, vol. 6, no. 3, pp. 70-77.

17. Zhukova S. I., Antonov V. A., Dem'yanova O. B., Abdrakhmanova R. O. Problema ekstrennoy profilaktiki infektsionnykh bolezney (obzor) [The problem of emergency prevention of infectious diseases (review)]. Volgogradskiy nauchno-meditsinskiy zhurnal [Volgograd Medical Journal], 2015, no. 1 (45), рр. 24-31.

18. Zemskov V. M., Zemskov A. M. Sovremennaya kontseptsiya i obshchie zakonomernosti immunomoduliru- yushchey terapii [Modern concept and general patterns of immunomodulatory therapy]. Uspekhi sovremennoy biologii [Successes of modern biology], 2014, vol. 134, no. 1, рр. 26-34.

19. Ivanova I. A., Telesmanich N. R., Kruglikov V. D. Sovremennoe sostoyanie voprosa i perspektivy razvitiya nespetsificheskoy profilaktiki kholery [The current state of the issue and the prospects for the development of nonspecific cholera prevention]. Zdorov'e natsii i sreda obitaniya [Nation Health and Habitat], 2012, no. 4, рр. 15-17.

20. Ilyukhin V. I., Viktorov D. V., Piven' N. N., Abramenko A. V., Timoshin V. B. Perekrestno-reagiruyushchie antigeny patogennykh burkkhol'deriy i nekotorykh opasnykh vozbuditeley infektsionnykh bolezney [Cross-reactive antigens of pathogenic Burkholderia and some dangerous pathogens of infectious diseases]. Zhurnal mikrobiologii, epi- demiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology], 2005, no. 2, рр. 14-19.

21. Karaulov A. V. Kliniko-immunologicheskaya effektivnost' primeneniya imunofana pri opportunisticheskikh infektsiyakh [Clinical and immunological efficacy of imunofan for opportunistic infections]. Lechashchiy vrach [Attending doctor], 2000, no. 4, рр. 52-55.

22. Kvetnaya A. S., Bekhtereva M. K., Zheleznova L. I., Kalinogorskaya O. S. Primenenie tsikloferona v kom- pleksnoy terapii sal'monelleznoy i iersinioznoy infektsii u detey [The use of cycloferon in the treatment of salmonella and yersiniosis infections in children]. Antibiotiki i khimioterapiya [Antibiotics and Chemotherapy], 2012, no. 3-4, рр. 9-16.

23. Kogotkova O. I., Overchenko V. V., Efremenko E. I. Povyshenie effektivnosti antibiotikoterapii sibirskoy yazvy v eksperimente [Improving the effectiveness of antibiotic treatment of anthrax in the experiment]. Antibiotiki i khimioterapiya [Antibiotics and Chemotherapy], 2002, vol. 47, no. 12, рр. 27-30.

24. Krasil'nikov I. V. Perspektivy razvitiya rynka rekombinantnykh preparatov [Prospects for the development of the market of recombinant drugs]. Farmatsevticheskiy vestnik [Pharmaceutical Herald], 2005, vol. 16, no. 379, р. 26.

25. Kuznetsov N. I., Kabanova V. I., Konusova V. G., Zhakhov A. V., Simbirtsev A. S., Semenov A. V. Rezul'taty ispol'zovaniya rekombinantnykh preparatov interleykina-1Я i interferona a-2b v terapii bol'nykh khroniches- kim virusnym gepatitom С [Application of interleukin-1Я and interferon a-2b recombinant drugs in therapy of chronic viral hepatitis C patients]. Klinicheskie perspektivy gastroenterologii, gepatologii [Clinical perspectives in gastroenterology and hepatology], 2006, no. 5, рр. 10-16.

26. Kuznetsova R. N., Sysoev V. V., Lebedev A. V, Tutel'yan A. A., Totolyan A. A. Osobennosti izmeneniy mestnogo immuniteta u bol'nykh s khronicheskim adenoiditom i vozmozhnosti ikh korrektsii preparatom imunofan [Features of changes in local immunity in patients with chronic adenoiditis and the possibility of their correction with Imunofan]. Meditsinskaya immunologiya [Medical immunology], 2008, vol. 10, no. 6, рр. 551-562.

27. Kuznik B. I., Tsybikov M. N., Likhanov I. D., Borshchevskiy V. S., Tsepelev V. L., Maslo E. Yu., Tsybikov N. N. Deystvie imunofana na uroven' provospalitel'nykh tsitokinov i pokazateli sistemnoy vospalitel'noy reaktsii u bol'nykh s ostrym gnoynym peritonitom [Effect of imunofan on the level of pro-inflammatory cytokines and indicators of systemic inflammatory response in patients with acute purulent peritonitis]. Annaly khirurgii [Annals of Surgery], 2012, no. 3, рр. 30-33.

28. Kukarkin N. Yu. Kliniko-immunologicheskaya effektivnost' bestima u bol'nykh vtorichnym pielonefritom v rannem posleoperatsionnom periode. Dissertatsiya kandidata meditsinskikh nauk [ Clinical and immunological efficacy of bestim in patients with secondary pyelonephritis in the early postoperative period. Thesis of Candidate of Medical Sciences]. Chelyabinsk, 2006, 157 р.

29. Lazareva D. N., Samigullina L. I., Morugova T. V. Immunomodulyatory [Immunomodulators]. Ufa, Zdravookhranenie Bashkortostana [Bashkortostan Health Care], 2012, 258 р.

30. Lebedeva I. A. Geterologichnye vaktsiny kak nespetsificheskie immunomodulyatory pri ekstrennoy profilaktike eksperimental'nogo melioidoza [Heterologous vaccines as non-specific immunomodulators in the emergency prevention of experimental melioidosis]. Tsitokiny i vospalenie [Cytokines and inflammation], 2017, vol. 16, no. 3, рр. 88.

31. Lebedeva I. A., Toporkov A. V., Zhukova S. I., Rotov K. A., Snatenkov E. A. Sinteticheskie peptidy i re- kombinantnye tsitokiny v skheme ekstrennoy profilaktiki eksperimental'nogo melioidoza [Synthetic peptides and recombinant cytokines in the scheme of emergency prophylaxis of experimental melioidosis]. Tsitokiny i vospalenie [Cytokines and inflammation], 2016, vol. 15, no. 2, рр. 181-185.

32. Maleev V. V., Onishchenko G. G., Fedorov Yu. M., Kutyrev V. V., Ryzhko I. V., Alekseev V. V., Kulichenko A. N., Malov I. V., Pokrovskiy V. I. Ekstrennaya profilaktika i lechenie opasnykh infektsionnykh bolezney. Metodicheskie rekomendatsii [Emergency prevention and treatment of dangerous infectious diseases. Guidelines]. Ed. V. V. Maleev. Moscow, 2009, 128 р.

33. Mamchur V. I., Levykh A. E. Defenziny - endogennye peptidy s antiinfektsionnymi i protivoopukholevymi svoystvami (obzor literatury) [Defensins - endogenous peptides with anti-infective and anti-tumor properties (literature review)]. Tavricheskiy mediko-biologicheskiy vestnik [Tauride Medical and Biological Herald], 2012, vol. 15, no. 2-3, рр. 315-321.

34. Markina O. V., Alekseeva L. P., Markin N. V., Telesmanich N. R. Vliyanie ekstraktov rasteniy na aktivnost' kholernogo toksina Vibrio cholerae [The effect of plant extracts on the activity of the cholera toxin Vibrio cholera]. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology], 2013, no. 1, рр. 9-13.

35. Marchenko V. I., Denisov L. A. Terapevticheskiy potentsial granulotsitarnogo koloniestimuliruyushchego faktora v lechenii infektsionno-vospalitel'nykh zabolevaniy cheloveka[Therapeutic potential of granulocyte colony- stimulating factor in the treatment of infectious and inflammatory human diseases]. Infektsionnye bolezni [Infectious diseases], 2006, vol. 4, no. 2, рр. 59-62.

36. Musalimova G. G., Saperov V. N., Markov D. S., Voropaeva L. A., Rakhimzyanov A. R., Nagaeva Yu. M. Kliniko-immunologicheskaya otsenka effektivnosti primeneniya rekombinantnogo interleykina-2 cheloveka (ron- koleykina) v kompleksnom lechenii pnevmoniy mikoplazmennoy i khlamidiynoy etiologii [Clinical and immunological evaluation of the effectiveness of the use of recombinant human interleukin-2 (Roncoleukin) in the complex treatment of pneumonia of mycoplasma and chlamydia etiology]. Vestnik covremennoy klinicheskoy meditsiny [Bulletin of modern clinical medicine], 2009, vol. 1, no. 2, рр. 14-20.

37. Nedel'skaya S. N. Innovatsionnyy podkhod k lecheniyu i profilaktike respiratornykh infektsiy u detey s ispol'zovaniem bakterial'nykh lizatov [Innovative approach to the treatment and prevention of respiratory infections in children using bacterial lysates]. Zdorov'e rebenka [Child health], 2010, vol. 5, no. 26, рр. 79-83.

38. Nemirovskaya T. I., Kovtun V. P., Abramtseva M. V., Aleksandrova N. V., Tarasov A. P., Salakhova R. D., Volkov V. A., Merkulov V. A. Immunomodulyatory bakterial'noy prirody, zaregistrirovannye v Rossiyskoy Federatsii [Immunomodulators of bacterial nature, registered in the Russian Federation]. Biopreparaty [Biologics], 2014, no. 3, рр. 19-26.

39. Nikolaeva T. N., Grigor'eva E. A., Kozlov V. V., Pronin A. V. Kompleksnye effekty “sal'mozana” i probi- oticheskikh bakteriy roda Lactobacillus na estestvennuyu rezistentnost' i adaptivnyy immunnyy otvet eksperimen- tal'nykh zhivotnykh [The combined effects of “salmozan” and probiotic bacteria of the genus Lactobacillus on the natural resistance and adaptive immune response of experimental animals]. Meditsinskaya immunologiya [Medical immunology], 2010, vol. 12, no. 1-2, рр. 81-86.

40. Omel'chenko N. D., Filippenko A. V., Doroshenko E. P., Bespalova I. A., Ivanova I. A., Morozova I. V., Trukhachev A. L., Galicheva A. L. Sovremennye aspekty nespetsificheskoy profilaktiki i lecheniya psevdotuberkuleza i kishechnogo iersinioza [Modern aspects of non-specific prevention and treatment of pseudotuberculosis and intestinal yersiniosis]. Natsional'nyy prioritety Rossii [National priorities of Russia], 2014, vol. 3, no. 13, рр. 80-84.

41. Ostrovskaya P. Yu., Flaks G. A., Korsunskaya I. M., Syuch N. I. Glutoksim v kompleksnoy terapii urogeni- tal'nykh infektsiy u patsientov reproduktivnogo vozrasta [Glutoxim in the treatment of urogenital infections in patients of reproductive age]. Vestnik Sankt-Peterburgskogo universiteta. Seriya: meditsina [Bulletin of St. Petersburg University. Series: medicine], 2011, no. 2, рр. 139-146.

42. Poddubnyak O. P., Galitskiy L. A., Simbirtsev A. S., Stepanov A. V. Otsenka klinicheskoy effektivnosti i immunomoduliruyushchego deystviya betaleykina v kompleksnom lechenii tuberkuleza legkikh u vpervye v yyavlen- nykh bol'nykh [Evaluation of the clinical efficacy and immunomodulatory effects of betaleukin in the complex treatment of pulmonary tuberculosis in newly diagnosed patients]. Tsitokiny i vospalenie [Cytokines and inflammation], 2007, vol. 6, no. 4, рр. 48-53.

43. Sanin A. V., Vasil'ev I. K., Bozhkov D. V. Opyt primeneniya preparata sal'mozan [Experience with salmozan]. Veterinariya Kubani [Veterinary Kuban], 2007, no. 5, рр. 23-24.

44. Semash N. A., Belevskiy A. S., Vyaz'menova N. I. Ad"yuvantnaya terapiya vnebol'nichnoy pnevmonii [Adjuvant therapy of community-acquired pneumonia]. Lechebnoe delo [Medical business], 2011, no. 4, рр. 50-54.

45. Semenov V. M., Dmitrachenko T. I., Kozin V. M., Zhil'tsov I. V., Piskun D. V., Zen'kova S. K., Semenov D. M., Kuchko I. V. Rukovodstvo po infektsionnym boleznyam [Infectious Disease Guide]. Moscow, Meditsinskoe informatsionnoe agentstvo [Medical Information Agency], 2008, 744 р.

46. Simbirtsev A. S. Interleykin-1. Fiziologiya, patologiya, klinika [Interleukin-1. Physiology, pathology, clinic]. Saint Petersburg, Folio, 2011, 480 p.

47. Timchenko V. N., Kalinina N. M., Barakina E. V., Pavlova E. B., Bulina O. V., Davydova N. I., Bychkova N. V, Bragina G. S. Opyt primeneniya viferona v kompleksnoy terapii detey, bol'nykh psevdotuberkulezom [Experience of using Viferon in the treatment of children with pseudotuberculosis]. Tsitokiny i vospalenie [Cytokines and inflammation], 2013, vol. 12, no. 1-2, рр. 159-165.

48. Titov L. P., Kartel' A. I., Shaban Zh. G. Ispol'zovanie prodigiozana i taktivina v lechenii bol'nykh khronicheskimi klebsiellezami [Use of Prodigiosan and Tactivin in the Treatment of Patients with Chronic Klebsiella infections]. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology], 2001, no. 5, рр. 46-49.

49. Fedorov Yu. N., Klyukina V. I., Romanenko M. N., Bogomolova O. A., Denisenko A. N. Strategiya i print- sipy immunokorrektsii i immunomoduliruyushchey terapii [Strategy and principles of immunocorrection and immunomodulatory therapy]. Vestnik Novgorodskogo gosudarstvennogo universiteta im. Yaroslava Mudrogo [Vestnik of Yaroslav the Wise Novgorod State University], 2015, no. 3-1 (86), рр. 84-87.

50. Filippenko A. V., Omel'chenko N. D., Ivanova I. A., Bespalova I. A., Doroshenko E. P., Galicheva A. L. Nekotorye aspekty nespetsificheskoy profilaktiki i lecheniya osobo opasnykh infektsiy [Some aspects of non-specific prevention and treatment of especially dangerous infections]. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology], 2015, no. 5, рр. 111-116.

51. Khabarova I. A., Toporkov A. V., Viktorov D. V., Zhukova S. I., Rotov K. A., Snatenkov E. A. Ekstrennaya profilaktika eksperimental'nogo melioidoza s ispol'zovaniem sinteticheskikh immunomodulyatorov i geterologichnykh vaktsin [Emergency prevention of experimental melioidosis using synthetic immunomodulators and heterologous vaccines]. Vestnik Rossiyskogo universiteta druzhby narodov. Seriya: Meditsina [Bulletin of Peoples' Friendship University of Russia. Series: Medicine], 2018, vol. 22, no. 3, рр. 340-350.

52. Khaitov R. M., Ataullakhanov R. I. Immunoterapiya. Rukovodstvo dlya vrachey [Immunotherapy. A guide for doctors]. Moscow, GEOTAR-Media, 2014, 672 р.

53. Tseneva G. Ya., Demakova T. E., Simbirtsev A. S., Voskresenskaya E. A., Kurova N. N., Chmyr' I. A., Lipatova L. A. Vliyanie rekominantnogo interleykina 1Я na eksperimental'nyy psevdotuberkuleznyy protsess [The effect of recombinant interleukin 1Я on an experimental pseudotuberculosis process]. Materialy Rossiyskoy nauchno- prakticheskoy konferentsii “Infektsionnye bolezni: covremennye problemy diagnostiki i lecheniya” [Materials of the Russian scientific-practical conference “Infectious diseases: modern problems of diagnosis and treatment”]. Moscow, Saint Petersburg, 2008, pр. 282-283.

54. Tsyrkunov V. M. Protivoepidemicheskie meropriyatiya v ochagakh infektsionnykh bolezney: Uchebnoe po- sobie / pod redaktsiey G. N. Chistenko [Anti-epidemic measures in the foci of infectious diseases: Study Guide]. Ed.

G. N. Chistenko. Minsk, Belorusskiy gosudarstvennyy meditsinskiy universitet [Belarusian State Medical University], 2006, 324 p.

55. Shpotin V. P., Galimzyanov Kh. M., Eremina N. V., Proskurin A. I. Effektivnost' imunofana v korrektsii tsi- tokinovogo statusa u bol'nykh khronicheskim gnoynym srednim otitom [The imunofan efficiency in the correction of cytokine status in patients with chronic purulent otitis media], Astrakhanskiy meditsinskiy zhurnal [Astrakhan Medical Journal], 2012, vol. 7, no. 3, рр. 185-188.

56. Yushkov V. V., Yushkova T. A., Larionov A. S. Farmakologiya immunokorrektorov [Immunocorrector Pharmacology]. Ekaterinburg, Ural'skiy tsentr meditsinskoy i farmatsevticheskoy informatsii [Ural Center for Medical and Pharmaceutical Information], 2005, 163 p.

57. Barnes J. L., Warner J., Melrose W., Durrheim D., Speare R., Reeder J. C., Ketheesan N. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Clin. Immunol., 2004, vol. 113, no. 1, рр. 22-28.

58. Dance D. Treatment and prophylaxis of melioidosis. Internation. J. of Antimicrobial Agents, 2014, vol. 43, no. 4, рр. 310-318.

59. Daya M., Nakamura Y. Pulmonary disease from biological agents: anthrax, plague, Q fever and tularemia. Crit. Care. Clin., 2005, vol. 21, no. 4, рр. 747-763.

60. Cheng A. C., Stephens D. P., Anstey N. M., Currie B. J. Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin. Infect. Dis., 2004, vol. 38, no. 1, рр. 32-37.

61. Cheng A. C., Limmathurotsakul D., Chierakul W., Getchalarat N., Wuthiekanun V., Stephens D. P., Day N. P., White N. J., Chaowagul W., Currie B. J., Peacock S. J. A randomized controlled trial of granulocyte colony- stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin. Infect. Dis., 2007, vol. 45, no. 3, рр. 308-314.

62. Cheng A. C., Dasari P., Currie B. Y. Granulocyte colony-stimulating factor and in vitro whole blood model of melioiodosis. Eur. J. Clin. Microbiol. Infect. Dis., 2004, vol. 23, no. 3. рр. 205-207.

63. Chitu V., Stanley Е. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol., 2006, no. 18, рр. 39-48.

64. Garcia A. E., Osapay G., Tran P. A., Yuan J. Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Selsted ME. Infect Immun., 2008, vol. 76, no. 12, рр. 5883-5891.

65. Haque, A., Easton A., Smith D., O'Garra A., Van Rooijen N., Lertmemongkolchai G., Titball R. W., Bancroft G. J. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection.

J. Infect. Dis., 2006, vol. 193, no. 3, рр. 370-379.

66. Lauw F. N., Simpson A. J., Prins J. M., van Deventer S. J., Chaowagul W., White N. J., van der Poll T. The CXC chemokines gamma interferon (IFN-gamma) - inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis. Infect. Immun., 2000, vol. 68, рр. 2034-2042.

67. Nicamp F. P., Parnham M. J. Principles of Immunopharmacology. Springer, 2011, 760 p.

68. Pammit M. A. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection. Antimicrob Agents Chemother, 2004, vol. 48, no. 12, рр. 4513-4519.

69. Propst K. L., Troyer R. M., Kellihan L. M., Schweizer H. P., Dow S. W. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob. Agents Chemother, 2010, vol. 54, no. 5, рр. 1785-1792.

70. Santanirand P., Harley V. S., Dance D. A., Drasar B. S., Bancroft G. J. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun., 1999, vol. 67, рр. 3593-3600.

71. Sharm, A., Patel V. K., Chaturvedi A. N. Vibriocidal activity of certain medicinal plants in Indian folklore medicine by tribals of Mahakoshal region of central India. Indian J. Pharmacol., 2009, vol. 41, no. 3, рр. 129-133.

72. Skyberg J. A. Nasal acai polysaccharides potential innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei infections. PLoS Pathog., 2012, vol. 8, no. 3, e 1002587.

73. Stephens D. P., Thomas J. H., Higgins A., Bailey M., Anstey N. M., Currie B. J., Cheng A. C. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Crit. Care Med., 2008, vol. 36, no. 2, рр. 448-454.

74. Utaisincharoen P., Anuntagool N., Arjcharoen S., Limposuvan K., Chisuria P., Sirisinha S. Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei nfected mouse macrophages. Exp. Immunol., 2004, vol. 136, no. 2, рр. 277-283.

75. Wiersinga W. J., Wieland K. U., van der Windt H. J. V., de Bourg A., Florkin S., Dondorp A., Day N. P., Peacock Sh. J., van der Poll T. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect. Immun., 2007, vol. 75, no. 8, рр. 3739-3746.

76. Wiersinga W. J., van der Poll T., White N. J., Day N. P., Koh S. G., Peacock S. J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Europ. J. Clin. Microbiol and Inf. Dis., 2012, vol. 31, no. 4, рр. 379-388.

77. Xiao B. G., Lu C. Z., Lin Н. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection. J. Cel. Mol. Med., 2007, vol. 11, no. 6, рр. 1272-1290.

78. Yamasaki S., Asakura M., Neogi S. B., Hinenoya A., Iwaoka E., Aoki S. Inhibition of virulence potential of Vibrio cholerae by natural compounds. Indian J. Med. Res., 2011, vol. 133, no. 2, рр. 232-239.

Размещено на Allbest.ru